• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国非裔美国人和白人美国人高血压并发症的患病率及对不同治疗方法的反应

Prevalence of complications and response to different treatments of hypertension in African Americans and white Americans in the U.S.

作者信息

Jamerson K A

机构信息

Department of Internal Medicine, University of Michigan Medical School, Ann Arbor 48109-0356.

出版信息

Clin Exp Hypertens. 1993 Nov;15(6):979-95. doi: 10.3109/10641969309037086.

DOI:10.3109/10641969309037086
PMID:8268902
Abstract

The aim of this review is to compare the prevalence of complications and response to different treatment for hypertension in African and European Americans. African Americans when compared to European Americans respond less favorably to beta-blockers (BB's) and angiotensin converting enzyme inhibitors (ACEI's). Nevertheless the observed response of African Americans to ACEI's and BB's is significant and these agents are very effective in this subgroup. African American race is not a clinically significant predictor of poor response to any class of antihypertensive therapy and there is little justification to use racial profiling as a criterion for choice of medication. Evidence to restrict or defer usage of BB's and ACEI's in African Americans is lacking. The mortality from hypertensive heart disease, stroke, and the incidence of hypertensive renal disease is higher in African Americans which leads some investigators to postulate that hypertension in African Americans is intrinsically different from whites. They therefore search for a separate etiology and suggest specific approaches to treatment. Awareness of racial differences in hypertension outcomes evolved in the U.S. in an historical context that does not fully appreciate that race is often a surrogate for many social and economic factors that influence health status and health care delivery in the U.S. Poor outcomes in African Americans occur in many diseases including hypertension.

摘要

本综述的目的是比较非裔美国人和欧裔美国人高血压并发症的患病率以及对不同治疗方法的反应。与欧裔美国人相比,非裔美国人对β受体阻滞剂(BBs)和血管紧张素转换酶抑制剂(ACEIs)的反应较差。然而,非裔美国人对ACEIs和BBs的观察反应是显著的,这些药物在该亚组中非常有效。非裔美国人种族并非对任何一类抗高血压治疗反应不佳的临床显著预测因素,几乎没有理由将种族特征作为药物选择的标准。缺乏限制或推迟非裔美国人使用BBs和ACEIs的证据。非裔美国人中高血压性心脏病、中风的死亡率以及高血压肾病的发病率较高,这使得一些研究人员推测非裔美国人的高血压与白人本质上不同。因此,他们寻找单独的病因并提出具体的治疗方法。在美国,对高血压结局种族差异的认识是在一个历史背景下发展起来的,而这个背景并没有充分认识到种族往往是许多社会和经济因素的替代指标,这些因素影响着美国的健康状况和医疗服务提供。非裔美国人在包括高血压在内的许多疾病中都有不良结局。

相似文献

1
Prevalence of complications and response to different treatments of hypertension in African Americans and white Americans in the U.S.美国非裔美国人和白人美国人高血压并发症的患病率及对不同治疗方法的反应
Clin Exp Hypertens. 1993 Nov;15(6):979-95. doi: 10.3109/10641969309037086.
2
The impact of ethnicity on response to antihypertensive therapy.种族对降压治疗反应的影响。
Am J Med. 1996 Sep 30;101(3A):22S-32S. doi: 10.1016/s0002-9343(96)00265-3.
3
Difficult-to-treat hypertensive populations: focus on African-Americans and people with type 2 diabetes.难治性高血压人群:聚焦非裔美国人和2型糖尿病患者。
J Hypertens Suppl. 1999 Feb;17(1):S19-24.
4
Is heart failure in African Americans a distinct entity?非裔美国人的心力衰竭是一种独特的病症吗?
Congest Heart Fail. 2003 Jul-Aug;9(4):193-6. doi: 10.1111/j.1527-5299.2003.01466.x.
5
Hypertension-related morbidity and mortality in African Americans--why we need to do better.非裔美国人中与高血压相关的发病率和死亡率——我们为何需要做得更好。
J Clin Hypertens (Greenwich). 2006 Jan;8(1 Suppl 1):21-30. doi: 10.1111/j.1524-6175.2006.05295.x.
6
The management of hypertension in African Americans.非裔美国人高血压的管理
Crit Pathw Cardiol. 2007 Jun;6(2):67-71. doi: 10.1097/HPC.0b013e318053da59.
7
Recognition and Management of Hypertension in Older Persons: Focus on African Americans.老年人高血压的识别与管理:聚焦非裔美国人。
J Am Geriatr Soc. 2015 Oct;63(10):2130-8. doi: 10.1111/jgs.13672.
8
Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study.高血压和痴呆症退伍军人用药方面的种族/族裔差异:一项全国队列研究。
Ann Pharmacother. 2009 Feb;43(2):185-93. doi: 10.1345/aph.1L368. Epub 2009 Feb 3.
9
Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.低肾素性高血压患者使用血管紧张素II受体阻滞剂的理论依据。
Am J Kidney Dis. 2000 Sep;36(3 Suppl 1):S24-30. doi: 10.1053/ajkd.2000.9688.
10
Racial differences in medication compliance and healthcare utilization among hypertensive Medicaid recipients: fixed-dose vs free-combination treatment.高血压医疗补助受助者在药物依从性和医疗保健利用方面的种族差异:固定剂量与自由组合治疗
Ethn Dis. 2008 Spring;18(2):204-9.

引用本文的文献

1
Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST).国际维拉帕米缓释片-群多普利研究(INVEST)中血压控制及临床结局的全球差异
Clin Cardiol. 2005 Jul;28(7):321-8. doi: 10.1002/clc.4960280704.
2
Diabetes mellitus and hypertension: key risk factors for kidney disease.糖尿病和高血压:肾脏疾病的关键危险因素。
J Natl Med Assoc. 2002 Aug;94(8 Suppl):7S-15S.